JPS5569515A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
JPS5569515A
JPS5569515A JP14110178A JP14110178A JPS5569515A JP S5569515 A JPS5569515 A JP S5569515A JP 14110178 A JP14110178 A JP 14110178A JP 14110178 A JP14110178 A JP 14110178A JP S5569515 A JPS5569515 A JP S5569515A
Authority
JP
Japan
Prior art keywords
metal salt
antibiotic substance
salt
amino
renal disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14110178A
Other languages
Japanese (ja)
Inventor
Tetsutaro Niisato
Takemi Koeda
Shigeharu Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP14110178A priority Critical patent/JPS5569515A/en
Publication of JPS5569515A publication Critical patent/JPS5569515A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To prepare a pharmaceutical composition having reduced side effects to the patient of renal disorder, by compounding an amino-glycoside antibiotic substance and a specific metal salt.
CONSTITUTION: A composition composed of (A) an amino-glycoside antibiotic substance (kanamycin, neomycin, gentamicin, etc.) and (B) a metal salt selected from organic or inorganic acid alkali metal salt, magnesium salt, cesium salt or rubidium salt (e.g. sodium pyruvate, potassium chloride, or potassium sulfate). The molar ratio of (A) to (B) is pref. 1:2W5. The addition of the low-cost metal salt to the antibiotic substance alleviates the exaggeration of the side effects such as the eight nerve crisis and renal disorder caused by the administration of an amino-glycoside antibiotic substance to the patient of renal disorder.
COPYRIGHT: (C)1980,JPO&Japio
JP14110178A 1978-11-17 1978-11-17 Pharmaceutical composition Pending JPS5569515A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14110178A JPS5569515A (en) 1978-11-17 1978-11-17 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14110178A JPS5569515A (en) 1978-11-17 1978-11-17 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
JPS5569515A true JPS5569515A (en) 1980-05-26

Family

ID=15284203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14110178A Pending JPS5569515A (en) 1978-11-17 1978-11-17 Pharmaceutical composition

Country Status (1)

Country Link
JP (1) JPS5569515A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6092212A (en) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd Pharmaceutical of doxorubicin salt
FR2557453A1 (en) * 1983-12-29 1985-07-05 Virbac Ctre Rech Biolog Antibacterial medicinal and veterinary compsn.
JPS62292722A (en) * 1986-06-12 1987-12-19 Nippon Kayaku Co Ltd Novel platinum complex pharmaceutical preparation
WO1996024363A1 (en) * 1995-02-10 1996-08-15 John Lai Therapeutic methods and preparations using rubidium ions
KR100416847B1 (en) * 2000-12-15 2004-02-05 메타볼랩(주) Pharmaceutical Compositions for Reducing the Toxicity
KR20180129678A (en) 2017-05-26 2018-12-05 스미또모 가가꾸 가부시키가이샤 Nonaqueous electrolyte seconday battery

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6092212A (en) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd Pharmaceutical of doxorubicin salt
FR2557453A1 (en) * 1983-12-29 1985-07-05 Virbac Ctre Rech Biolog Antibacterial medicinal and veterinary compsn.
JPS62292722A (en) * 1986-06-12 1987-12-19 Nippon Kayaku Co Ltd Novel platinum complex pharmaceutical preparation
WO1996024363A1 (en) * 1995-02-10 1996-08-15 John Lai Therapeutic methods and preparations using rubidium ions
AU696938B2 (en) * 1995-02-10 1998-09-24 John Lai Therapeutic methods and preparations using rubidium ions
US6011061A (en) * 1995-02-10 2000-01-04 Lai; John Therapeutic methods and preparations using rubidium ions
KR100416847B1 (en) * 2000-12-15 2004-02-05 메타볼랩(주) Pharmaceutical Compositions for Reducing the Toxicity
KR20180129678A (en) 2017-05-26 2018-12-05 스미또모 가가꾸 가부시키가이샤 Nonaqueous electrolyte seconday battery

Similar Documents

Publication Publication Date Title
JPS5241612A (en) Granular or powdered detergent compositions
JPS5569515A (en) Pharmaceutical composition
CA2067733A1 (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
JPS543087A (en) Preparation of cephalosporin compound
CA2016470A1 (en) Pharmaceutical preparation and method of treatment for liver dysfunction
ES8501763A1 (en) Novel derivative of thienopyridinone, its preparation and its therapeutic use.
JPS5392767A (en) Preparation of 2-phthalimidomethylindole derivatives
JPS5386011A (en) Preparation of paste
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS5312414A (en) Production of preparation containing stable 1alpha-hydroxyvitamines d
JPS52285A (en) Preparation of n1 *22tetrahydrofuryl**55fluorouracil
JPS54147933A (en) Anti-microbial agent
JPS52125194A (en) Stabilized s-adenosyl-l-methionine composition
EP0294069A3 (en) Purine compounds, process for their preparation, intermediates and pharmaceutical compositions
JPS5282791A (en) Preparation of 7-amino compounds
JPS5345358A (en) Preparation of easily water-dispersible sodium carboxymethyl cellulose
IE42478L (en) Pharmaceutical composition
JPS5750919A (en) Agent for reducing side effect
JPS53119820A (en) Preparation of alkali aminodiacetate
JPS5677298A (en) Movel 5-fluorouridine derivative and its preparation
JPS5231094A (en) Preparation of cephalexin
JPS5379856A (en) Preparation of optical active 1-methyl-2-(beta-hydroxyethyl)pyrrplidive
JPS5371066A (en) Preparation of 3-phenylindole derivs.
JPS5271440A (en) Preparation of optically active p-hydroxyphenylglycines
JPS53119822A (en) Preparation of 2-dimethylaminoethylisothiocyanate